Use Able AI chat for product recommendations

NKG2A/CD159a Polyclonal antibody

NKG2A/CD159a Polyclonal Antibody for WB, IHC, IF-P, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

WB, IHC, IF-P, ELISA

KLRC1, CD159 antigen-like family member A, CD159A, NK cell receptor A, NKG2

Formulation:  PBS, Azide, Glycerol
PBS, Azide, Glycerol
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 
SKU: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:

Able AI
Able AI
What's the best dilution for NKG2A/CD159a in ?

Tested Applications

Positive WB detected inhuman liver tissue
Positive IHC detected inhuman tonsillitis tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF-P detected inhuman tonsillitis tissue

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:1000
Immunohistochemistry (IHC)IHC : 1:500-1:2000
Immunofluorescence (IF)-PIF-P : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

10935-1-AP targets NKG2A/CD159a in WB, IHC, IF-P, ELISA applications and shows reactivity with human samples.

Tested Reactivity human
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen

CatNo: Ag1376

Product name: Recombinant human KLRC1 protein

Source: e coli.-derived, PGEX-4T

Tag: GST

Domain: 1-215 aa of BC012550

Sequence: MDNQGVIYSDLNLPPNPKRQQRKPKGNKSSILATEQEITYAELNLQKASQDFQGNDKTYHCKDLPSAPEKLIVGILGIICLILMASVVTIVVIPSRHCGHCPEEWITYSNSCYYIGKERRTWEESLLACTSKNSSLLSIDNEEEMKFLSIISPSSWIGVFRNSSHHPWVTMNGLAFKHEIKDSDNAELNCAVLQVNRLKSAQCGSSIIYHCKHKL

Predict reactive species
Full Name killer cell lectin-like receptor subfamily C, member 1
Calculated Molecular Weight 26 kDa
Observed Molecular Weight 33 kDa
GenBank Accession NumberBC012550
Gene Symbol NKG2A
Gene ID (NCBI) 3821
RRIDAB_2249683
Conjugate Unconjugated
FormLiquid
Purification MethodAntigen affinity purification
UNIPROT IDP26715
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

NKG2A, also known as CD159a or KLRC1, is a single-pass type II membrane protein with an extracellular C-type lectin domain. It belongs to the natural killer cell lectin-like receptor family, which is a group of transmembrane proteins preferentially expressed in NK cells. NKG2A can form a heterodimer with CD94. The NKG2A/CD94 complex is an inhibitory receptor that recognizes HLA-E and is expressed by NK cells and a subset of T cells.

Protocols

Product Specific Protocols
IF protocol for NKG2A/CD159a antibody 10935-1-APDownload protocol
IHC protocol for NKG2A/CD159a antibody 10935-1-APDownload protocol
WB protocol for NKG2A/CD159a antibody 10935-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

What published studies show

The NKG2A/CD159a Polyclonal antibody (Cat# 10935-1-AP) has 4 total citations. These appear in the journals Med, Cell Oncology, Discover Oncology, and PLoS One. The associated research fields include cancer immunology (HLA-E-overexpressing cancers, triple-negative breast cancer, colorectal cancer) and hematologic malignancy diagnosis (natural killer cell leukemia). Applications cited include Western blot and immunohistochemistry.

SpeciesApplicationTitle

Med

Targeting HLA-E-overexpressing cancers with a NKG2A/C switch receptor

Authors - Michelle Sætersmoen
humanWB

Cell Oncol (Dordr)

TAK-981 potentiates doxorubicin immunocide in triple-negative breast cancer by IFN I-dependent NK cell stimulation.

Authors - Jia Liu
humanWB,IHC

Discov Oncol

Tumor-intrinsic KLRC1 exerts tumor-suppressive functions in colorectal cancer.

Authors - Chao Wang

PLoS One

Flow Cytometric Immunophenotyping Is Sensitive for the Early Diagnosis of De Novo Aggressive Natural Killer Cell Leukemia (ANKL): A Multicenter Retrospective Analysis.

Authors - Yi Li
Loading...
||
New chat

Able®

正在加载,请稍候...